Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Influenza vaccination and asthma: current studies and recommendations.

Influenza vaccination and asthma: current studies and recommendations. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Influenza vaccination and asthma: current studies and recommendations. Abstract Text:

    i stephensonI Stephenson,k g nicholsonK G Nicholson,

    Influenza is an important epidemic and pandemic illness associated with serious morbidity and mortality in unprotected communities. Patients at increased risk of infection are those with pre-existing cardiopulmonary disease including asthma. The influenza virus has the ability to produce antigenic changes posing problems for vaccine development. Influenza vaccines have been available for over 50 years. Despite the continuing global threat posed by infection and recommendations in many countries that immunisation should be widely given, uptake rates are variable and often poor. It has been demonstrated that infection with influenza and other respiratory viral pathogens can produce exacerbations of asthma throughout the age groups. Despite this, vaccine uptake rates in asthmatic populations are quite low. Poor uptake rates are attributed to a number of factors and we review the evidence for the widely held view that influenza vaccination produces exacerbations of chronic airflow obstruction including asthma. Observational studies have found conflicting results: some post immunisation changes in bronchial hyperreactivity and increased requirements of bronchodilator therapy have been in some, but not all, studies. Placebo-controlled trials have not demonstrated any clinical deterioration although one study showed a small reduction in peak expiratory flow rate. Intranasal administration of cold-adapted live vaccines and new nucleic acid vaccines are briefly considered. Live adapted vaccines have been shown to be effective in influenza immunoprophylaxis and limited data on their use in patients with asthma suggest that they can be administered safely. In conclusion, based up on current studies and evidence, it seems likely that influenza infection produces morbidity in patients with asthma but that any potential adverse effects of influenza immunisation are outweighed by the benefits in this population. However, placebo-controlled trials are few and only small numbers of asthmatic patients have been investigated.

    Influenza vaccination and asthma: current studies and recommendations. Publishing Authors By Initials

    i stephensonI Stephenson,kg nicholsonKG Nicholson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Influenza vaccination and asthma: current studies and recommendations. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: BioDrugs : clinical immunotherapeutics, biopharmac

    VOLUME: 11

    Page Numbers: 223-8

    Journal Abbreviation:

    ISSN: 1173-8804

    DAY: 22

    MONTH: Apr

    YEAR: 1999

    Influenza vaccination and asthma: current studies and recommendations. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9705305

    Influenza vaccination and asthma: current studies and recommendations. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Influenza vaccination and asthma: current studies and recommendations. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Influenza vaccination and asthma: current studies and recommendations.

    AFFILIATION: Department of Infectious Diseases and Tropical Medicine, Leicester Royal Infirmary, Leicester, England.

    Country: New Zealand

    New Zealand Research PublicationNew Zealand Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: BioDrugs

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Influenza vaccination and asthma: current studies and recommendations Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News